'When you welcome well, you vaccinate well': a qualitative study on improving vaccination coverage in urban settings in Conakry, Republic of Guinea.
community health workers
mass vaccination
measles
qualitative research
vaccination
vaccination refusal
Journal
International health
ISSN: 1876-3405
Titre abrégé: Int Health
Pays: England
ID NLM: 101517095
Informations de publication
Date de publication:
01 12 2021
01 12 2021
Historique:
received:
12
07
2019
revised:
27
08
2019
accepted:
19
09
2019
pubmed:
14
1
2020
medline:
4
1
2022
entrez:
14
1
2020
Statut:
ppublish
Résumé
Recurrent measles outbreaks followed by mass vaccination campaigns (MVCs) occur in urban settings in sub-Saharan countries. An understanding of the reasons for this is needed to improve future vaccination strategies. The 2017 measles outbreak in Guinea provided an opportunity to qualitatively explore suboptimal vaccination coverage within an MVC among participants through their perceptions, experiences and challenges. We conducted focus group discussions with caregivers (n=68) and key informant interviews (n=13) with health professionals and religious and community leaders in Conakry. Data were audio-recorded, transcribed verbatim from Susu and French, coded and thematically analysed. Vaccinations were widely regarded positively and their preventive benefits noted. Vaccine side effects and the subsequent cost of treatment were commonly reported concerns, with further knowledge requested. Community health workers (CHWs) play a pivotal role in MVCs. Caregivers suggested recruiting CHWs from local neighbourhoods and improving their attitude, knowledge and skills to provide information about vaccinations. Lack of trust in vaccines, CHWs and the healthcare system, particularly after the 2014-2016 Ebola epidemic, were also reported. Improving caregivers' knowledge of vaccines, potential side effects and their management are essential to increase MVC coverage in urban settings. Strengthening CHWs' capacities and appropriate recruitment are key to improving trust through a community involvement approach.
Sections du résumé
BACKGROUND
Recurrent measles outbreaks followed by mass vaccination campaigns (MVCs) occur in urban settings in sub-Saharan countries. An understanding of the reasons for this is needed to improve future vaccination strategies. The 2017 measles outbreak in Guinea provided an opportunity to qualitatively explore suboptimal vaccination coverage within an MVC among participants through their perceptions, experiences and challenges.
METHODS
We conducted focus group discussions with caregivers (n=68) and key informant interviews (n=13) with health professionals and religious and community leaders in Conakry. Data were audio-recorded, transcribed verbatim from Susu and French, coded and thematically analysed.
RESULTS
Vaccinations were widely regarded positively and their preventive benefits noted. Vaccine side effects and the subsequent cost of treatment were commonly reported concerns, with further knowledge requested. Community health workers (CHWs) play a pivotal role in MVCs. Caregivers suggested recruiting CHWs from local neighbourhoods and improving their attitude, knowledge and skills to provide information about vaccinations. Lack of trust in vaccines, CHWs and the healthcare system, particularly after the 2014-2016 Ebola epidemic, were also reported.
CONCLUSIONS
Improving caregivers' knowledge of vaccines, potential side effects and their management are essential to increase MVC coverage in urban settings. Strengthening CHWs' capacities and appropriate recruitment are key to improving trust through a community involvement approach.
Identifiants
pubmed: 31927565
pii: 5700807
doi: 10.1093/inthealth/ihz097
pmc: PMC8643481
doi:
Substances chimiques
Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
586-593Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.
Références
Bull World Health Organ. 1993;71(5):549-60
pubmed: 8261558
PLoS Curr. 2015 Feb 02;7:
pubmed: 25713744
J Clin Epidemiol. 2005 Nov;58(11):1081-8
pubmed: 16223649
S Afr Med J. 2004 Oct;94(10):835-8
pubmed: 15532760
Bull World Health Organ. 1989;67(4):381-8
pubmed: 2805216
Vaccine. 2001 Mar 21;19(17-19):2440-5
pubmed: 11257375
Vaccine. 2009 Aug 27;27(39):5371-5
pubmed: 19616497
Public Health Action. 2017 Jun 21;7(Suppl 1):S1-S2
pubmed: 28744431
J Health Popul Nutr. 2009 Jun;27(3):358-67
pubmed: 19507751
Vaccine. 2016 Jul 29;34(35):4103-4109
pubmed: 27349841
Vaccine. 2018 Oct 22;36(44):6459-6463
pubmed: 29031695
Int J Equity Health. 2018 Nov 14;17(1):167
pubmed: 30428876
PLoS One. 2017 Mar 1;12(3):e0172310
pubmed: 28249006
Open Forum Infect Dis. 2017 Jul 18;4(3):ofx146
pubmed: 28948177
Soc Sci Med. 2014 Jul;112:1-11
pubmed: 24788111
EBioMedicine. 2016 Oct;12:295-301
pubmed: 27658738
Aust N Z J Public Health. 1998 Jun;22(4):441-6
pubmed: 9659770
Bull World Health Organ. 2015 May 1;93(5):314-9
pubmed: 26229202
Vaccine. 2011 Oct 26;29(46):8215-21
pubmed: 21893149
Indian Pediatr. 2005 Jul;42(7):653-63
pubmed: 16085966
Hum Vaccin Immunother. 2013 Aug;9(8):1763-73
pubmed: 23584253
Clin Pediatr (Phila). 1993 Jan;32(1):2-7
pubmed: 8419093
Vaccine. 2013 Apr 12;31(16):2011-23
pubmed: 23499565
Vaccine. 2018 Oct 22;36(44):6464-6472
pubmed: 28899629